《Table 2 Chemotherapy regimens and responses of patients with advanced gastric cancer》
提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Impact of time from diagnosis to chemotherapy in advanced gastric cancer: A Propensity Score Matching Study to Balance Prognostic Factors》
1Twenty-five patients were not evaluated(during first-line chemotherapy).WT:Waiting time;CR:Complete response;PR:Partial response;SD:Stable disease;PD:Progressive disease;NE:Not evaluated;RR:Response rate;DCR:Disease control rate.
The patient characteristics are shown in Table 1.The median WT from diagnosis to chemotherapy initiation was 17 d.Therefore,we set the time of 2 wk as the cutoff point to define patients as belonging in either the early WT group or the elective WT group.The early WT group was defined those having a WT of fewer than 14 d.The elective WT group was defined as those having a WT equal to or longer than 14 d.There were 46 patients in the early WT group and 64 patients in the elective WT group.The median WTs in the early WT and elective WT groups were 10 and 24 d,respectively.
图表编号 | XD0043288700 严禁用于非法目的 |
---|---|
绘制时间 | 2019.01.15 |
作者 | Tsutomu Nishida、Aya Sugimoto、Ryo Tomita、Yu Higaki、Naoto Osugi、Kei Takahashi、Kaori Mukai、Tokuhiro Matsubara、Dai Nakamatsu、Shiro Hayashi、Masashi Yamamoto、Sachiko Nakajima、Koji Fukui、Masami Inada |
绘制单位 | Department of Gastroenterology, Toyonaka Municipal Hospital、Department of Gastroenterology, Toyonaka Municipal Hospital、Department of Gastroenterology, Toyonaka Municipal Hospital、Department of Gastroenterology, Toyonaka Municipal Hospital、Department of G |
更多格式 | 高清、无水印(增值服务) |
查看“Table 2 Chemotherapy regimens and responses of patients with advanced gastric cancer”的人还看了
- Table 2 Univariate and multivariate analyses of variables influencing survival of 52 patients with colorectal cancer
- Table 1 Characteristics of 83 patients with hidradenitis suppurative, Nonalcoholic fatty liver and Nonalcoholic steatohe
- Table 3 Comparison of serological response in azithromycin-or BPG-treated early syphilis patients at 12-months follow-up